Bill Gates to Supply Coronavirus Test Kit
When the CDC admitted that the tests could not distinguish between COVID-19 and influenza viruses, then why are our governments ignorant of this? This shows that they have plans to get people to take unnecessary tests, and those costs can add up.
According to the CDC, PCR tests would soon no longer be available for emergency use to determine whether individuals have contracted COVID-19, and seemed to tacitly admit that the tests cannot differentiate between COVID-19 and influenza viruses. Many of National File’s readers noted that this development came less than one week after Bill Gates and George Soros announced their intention to buy a COVID-19 test manufacturer based in the United Kingdom.
Continue reading: https://nationalfile.com/cdc-declares-pcr-tests-must-go-immediately-after-george-soros-bill-gates-buy-covid-19-test-manufacturer/
Bill Gates and George Soros have joined efforts to acquire UK company Mologic, which developed Covid-19 rapid lateral flow tests.
Mologic Ltd. was purchased by Open Society Foundations, which George Soros founded.
Global Access Diagnostics Ltd and Mologic Ltd will combine their expertise in rapid diagnostic tests under one brand.
Using Bill & Melinda Gates Foundation funds, the Soros Economic Development Fund will invest at least £30 million ($41.1 million) in improving medical technology in developing countries.
In the agreement, Mologic and a sister company, Global Access Diagnostics, will be incorporated into a new business named Global Access Health.
Global Access Health (GAH) will be created by the foundation as a social enterprise to increase access to affordable, state-of-the-art medical technology for the Global South through decentralized research, development, and manufacturing.
( https://www.opensocietyfoundations.org/newsroom/new-social-enterprise-seeks-to-expand-affordable-global-access-to-healthcare )
TESTING SHOULD BE AVAILABLE TO EVERYONE ( HUMANITY TESTED )
( https://www.globalaccessdx.com )
Gates is undoubtedly raising funds for noble causes through his foundation, but he does so not merely for the sake of humankind but for his own profit.
It may be because the Gates Foundation holds a stake in CureVac, which has completed mRNA-based COVID vaccine clinical trials, that Gates won’t share vaccine formulations.
Mologic COVID self-tests, regardless of how affordable they become, it is likely that many people will give in to unnecessary tests, and those costs add up. Gates will be there with Soros to make a fortune.
The gates-funded program will soon offer home-testing kits for the new coronavirus
( https://www.seattletimes.com/seattle-news/health/gates-funded-program-will-soon-offer-home-testing-kits-for-new-coronavirus/ )
RT-PCR Test: Shocking Reality by Dr. Biswaroop Roy Chowdhury:
Additional Info:
Bill and Melinda Gates Foundation project 2: developing field-deployable RT-PCR for vector surveillance
In malaria vector control surveillance, data concerning many important indicators can only be collected via laboratory-based molecular tests (i.e., species confirmation of species complexes, molecular mechanisms of resistance, and Plasmodium infectivity). At present, transporting mosquitoes to laboratories for testing is a major rate-limiting step that can lead to months-long delays in receiving data, especially if there is no molecular lab in-country.
Recently, transportable RT-PCR machines have been developed for analyzing environmental samples and are being adapted to run mosquito diagnostic assays. This investment can support the development of protocols and field-stable reagents for mosquito assays as well as the testing of their feasibility for use in the field by collaborators in Africa. The overall goal of this project is to develop and evaluate a field-deployable, PCR-based insecticide resistance surveillance system in Cameroon. This insecticide resistance surveillance system will involve field-deployable preparation of mosquito DNA samples and a PCR-based insecticide marker diagnostic assay that can be performed in a cost-effective and user-friendly, portable bCUBE PCR machine linked to automatic data interpretation integrated with a centralized GIS database. The insecticide surveillance system will be designed for autonomous operation by National Malaria Control Program (NMCP) sentinel sites in Cameroon, and the generation of proof-of-principle data that will enhance our understanding of insecticide resistance dynamics in mosquito populations
( https://crid-cam.net/bill-and-melinda-gates-foundation-project-2-developing-field-deployable-rt-pcr-for-vector-surveillance/ )
You may also want to read my article: